ZVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
ZEVRA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$10.16+0.22 (+2.21%)
Close on Oct 19, 2026
- Market cap
- $623.18M
- P/E (TTM)
- 10.9
- Dividend yield
- –
SEC filings
40 of Zevra Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 20, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 17, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2025 | Dec 2, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 7, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 21, 2024 | Nov 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 20, 2024 | Sep 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 2, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 12, 2024 | Jul 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2024 | Jul 9, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2024 | Apr 10, 2024 | SEC EDGAR |